Efficacy and Safety of TargetCool + Benev Exosomes in Patients With Hair Thinning

NANot yet recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

May 31, 2026

Conditions
Hair DiseasesAlopeciaHair Thinning
Interventions
DEVICE

Scalp tattoo

A micropigmentation scalp tattoo will be applied at baseline to mark consistent photographic sites.

DEVICE

Canfield HairMetrix®

Canfield HairMetrix® imaging will be utilized to capture global and trichoscopic hair measurements.

DEVICE

TargetCool

Boosting will be used to apply exosomes

DEVICE

Microneedle-facilitated lidocaine application

Microneedling will be performed to a depth of 0.5 mm.

Trial Locations (1)

10021

Marc Avram MD, New York

All Listed Sponsors
collaborator

Benev Company, Inc.

INDUSTRY

lead

Recens Medical, Inc.

INDUSTRY